The pharmaceutical community is excited by retatrutide, a innovative dual GIP and GLP-1 receptor that’s showing remarkable results in early trials . This medication works by imitating natural hormones to impact appetite and promote feelings of satiety, ultimately resulting in substantial weight decrease. While currently under review and not readi